🇺🇸 SRPT — Sarepta Therapeutics, Inc.
Salud MantenerPrecio actual
17,82 USD
Máx. histórico
178,74
2145 días
Split 1:6 del 12/07/2012
Caída desde máximo
-90,03%
Rango 52 semanas
14,68 – 24,68
Variación hoy
+1,42%
Cierre anterior
17,57
Rango de hoy
17,52 – 18,77
Volumen hoy
2.596.193
Peor caída histórica
-98,17%
09/02/2000 → 18/12/2008
Recuperado en 3568 días
Volatilidad anualizada ⓘ
95,43%
- Nombre completo
- Sarepta Therapeutics, Inc.
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 835
- PER ⓘ
- —
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 21,64 USD (puede no estar actualizado)
- Primera cotización
- 04/06/1997
- Precio actualizado
- hace 11 horas
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.
| Fecha | Ratio |
|---|---|
| 12/07/2012 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 22/11/2017 | 56,09 | 56,50 | 55,60 | 56,22 | +0,66% | 1,60% | 1.363.900 |
| 21/11/2017 | 56,49 | 57,16 | 55,62 | 55,85 | -0,66% | 2,73% | 1.383.500 |
| 20/11/2017 | 55,81 | 56,69 | 55,71 | 56,22 | +0,20% | 1,76% | 1.692.200 |
| 17/11/2017 | 54,87 | 56,30 | 54,75 | 56,11 | +1,94% | 2,82% | 1.526.600 |
| 16/11/2017 | 54,81 | 55,51 | 54,20 | 55,04 | +1,05% | 2,39% | 1.502.000 |
| 15/11/2017 | 53,96 | 55,25 | 53,21 | 54,47 | -0,58% | 3,78% | 1.435.600 |
| 14/11/2017 | 54,59 | 55,43 | 53,75 | 54,79 | +0,55% | 3,08% | 1.643.200 |
| 13/11/2017 | 53,99 | 55,51 | 53,54 | 54,49 | +0,61% | 3,65% | 1.630.000 |
| 10/11/2017 | 51,94 | 54,31 | 51,86 | 54,16 | +3,81% | 4,72% | 2.422.000 |
| 09/11/2017 | 52,09 | 52,58 | 50,51 | 52,17 | -0,51% | 3,97% | 4.131.700 |
| 08/11/2017 | 54,35 | 54,66 | 52,41 | 52,44 | -6,11% | 4,14% | 3.630.000 |
| 07/11/2017 | 56,00 | 57,57 | 55,66 | 55,85 | +0,59% | 3,41% | 1.439.600 |
| 06/11/2017 | 53,78 | 57,29 | 53,70 | 55,52 | +3,85% | 6,68% | 3.161.600 |
| 03/11/2017 | 51,28 | 54,42 | 51,20 | 53,46 | +4,74% | 6,28% | 2.515.000 |
| 02/11/2017 | 49,03 | 51,23 | 48,77 | 51,04 | +3,34% | 5,02% | 1.443.700 |
| 01/11/2017 | 49,56 | 50,50 | 48,81 | 49,39 | +0,16% | 3,41% | 1.256.900 |
| 31/10/2017 | 47,64 | 50,00 | 47,25 | 49,31 | +2,84% | 5,77% | 1.564.700 |
| 30/10/2017 | 47,30 | 48,98 | 46,97 | 47,95 | +0,33% | 4,25% | 1.233.100 |
| 27/10/2017 | 48,24 | 48,77 | 46,13 | 47,79 | +0,31% | 5,47% | 1.872.000 |
| 26/10/2017 | 48,20 | 49,74 | 46,07 | 47,64 | -1,49% | 7,61% | 3.765.100 |
| 25/10/2017 | 49,39 | 50,04 | 47,12 | 48,36 | -1,23% | 5,91% | 2.979.900 |
| 24/10/2017 | 51,25 | 51,93 | 48,54 | 48,96 | -4,88% | 6,61% | 2.658.500 |
| 23/10/2017 | 52,24 | 52,57 | 51,21 | 51,47 | -0,90% | 2,60% | 1.894.700 |
| 20/10/2017 | 50,80 | 52,11 | 50,38 | 51,94 | +2,41% | 3,41% | 1.669.500 |
| 19/10/2017 | 50,42 | 51,00 | 49,15 | 50,72 | -1,36% | 3,67% | 1.584.500 |
| 18/10/2017 | 51,90 | 52,67 | 51,29 | 51,42 | -0,58% | 2,66% | 1.065.000 |
| 17/10/2017 | 51,03 | 51,83 | 50,75 | 51,72 | +1,95% | 2,12% | 1.030.900 |
| 16/10/2017 | 50,65 | 52,09 | 50,30 | 50,73 | +0,32% | 3,53% | 1.880.900 |
| 13/10/2017 | 51,00 | 51,29 | 50,37 | 50,57 | -1,38% | 1,80% | 1.229.100 |
| 12/10/2017 | 50,97 | 52,12 | 50,76 | 51,28 | +0,21% | 2,67% | 1.505.600 |